Literature DB >> 29622130

Comparison of Contrast-Enhanced Mammography and Contrast-Enhanced Breast MR Imaging.

John Lewin1.   

Abstract

Contrast-enhanced mammography (CEM) is a contrast-enhanced modality for breast cancer detection that utilizes iodinated contrast and dual-energy imaging performed on a digital mammography unit with only slight modifications. It is approved by the US Food and Drug Administration, commercially available, and in routine clinical use at centers around the world. It has similar sensitivity and specificity to MR Imaging and has advantages in terms of cost, patient acceptability, and examination time. MR Imaging has some advantages compared with CEM, especially in its ability to image the complete axilla and the chest wall.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast MR Imaging; Breast cancer detection; Contrast agent; Mammography

Mesh:

Substances:

Year:  2018        PMID: 29622130     DOI: 10.1016/j.mric.2017.12.005

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  8 in total

1.  Detection of noncalcified breast cancer in patients with extremely dense breasts using digital breast tomosynthesis compared with full-field digital mammography.

Authors:  Ann Yi; Jung Min Chang; Sung Ui Shin; A Jung Chu; Nariya Cho; Dong-Young Noh; Woo Kyung Moon
Journal:  Br J Radiol       Date:  2018-10-03       Impact factor: 3.039

2.  Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound.

Authors:  Xiaoling Leng; Guofu Huang; Lianhua Zhang; Jianbing Ding; Fucheng Ma
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

Review 3.  Occult breast cancer: Where are we at?

Authors:  Adam Ofri; Katrina Moore
Journal:  Breast       Date:  2020-10-27       Impact factor: 4.380

4.  Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.

Authors:  Liangliang Yu; Yongtao Wang; Dong Xing; Peiyou Gong; Qianqian Chen; Yongbin Lv
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.889

5.  Is Elevated Choline on Magnetic Resonance Spectroscopy a Reliable Marker of Breast Lesion Malignancy?

Authors:  Natasa Prvulovic Bunovic; Olivera Sveljo; Dusko Kozic; Jasmina Boban
Journal:  Front Oncol       Date:  2021-09-10       Impact factor: 6.244

6.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

7.  Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapy.

Authors:  Dong Xing; Ning Mao; Jianjun Dong; Heng Ma; Qianqian Chen; Yongbin Lv
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

8.  Diagnostic value of the enhancement intensity and enhancement pattern of CESM to benign and malignant breast lesions.

Authors:  Xiaoxiao Chi; Lei Zhang; Dong Xing; Peiyou Gong; Qianqian Chen; Yongbin Lv
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.